Novel and Optimized Diagnostics for Pediatric TB

Project Details

Description

In response to RFA AI-19-036, investigators from Rutgers University, Makerere University, the Foundation for Innovative New Diagnostics (FIND), McGill University, Frontier Sciences Boston, the US Centers for Disease Control and Prevention, the Kenyan Medical Research Institute and Oxford University propose to study Novel and Optimized Diagnostics (NOD) for Pediatric TB in a prospective study of well-characterized cohorts of children
StatusFinished
Effective start/end date5/7/204/30/24

Funding

  • National Institute of Allergy and Infectious Diseases: $219,999.00
  • National Institute of Allergy and Infectious Diseases: $1,085,066.00
  • National Institute of Allergy and Infectious Diseases: $219,999.00
  • National Institute of Allergy and Infectious Diseases: $1,088,847.00
  • National Institute of Allergy and Infectious Diseases: $1,122,443.00
  • National Institute of Allergy and Infectious Diseases: $1,119,258.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.